Chris De La Torre

Title: Chris De La Torre: Innovator in Genomic Analysis

Introduction

Chris De La Torre is a notable inventor based in Aliso Viejo, CA (US). He has made significant contributions to the field of genomic analysis, particularly in methods for detecting chromosome rearrangements in cancer-related samples. With a total of 2 patents, his work is pivotal in advancing diagnostic techniques in genomics.

Latest Patents

De La Torre's latest patents include innovative methods for detecting the presence or absence of chromosome rearrangements in formalin-fixed paraffin-embedded (FFPE) samples. These methods are crucial for identifying genomic variants associated with cancer. In one embodiment, the process involves selecting a sample, performing nucleic acid analysis, and determining the presence or absence of chromosome rearrangements based on the analysis. Another patent focuses on methods and compositions for preparing nucleic acids that maintain spatial-proximal contiguity information, which is essential for accurate genomic assessments.

Career Highlights

Chris De La Torre is currently associated with Arima Genomics, Inc., where he applies his expertise in genomic technologies. His work has been instrumental in developing advanced methodologies that enhance the understanding of genetic alterations in cancer.

Collaborations

Throughout his career, De La Torre has collaborated with esteemed colleagues such as Anthony Schmitt and Catherine Tan. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Chris De La Torre stands out as a key figure in the field of genomic analysis, with his patents reflecting a commitment to improving cancer diagnostics. His contributions continue to shape the future of genomic research and technology.